In vivo, iNOS expression is regulated not only by tumor-intrinsic signaling but also by dynamic interactions with infiltrating immune cells, stromal components, hypoxia, and cytokine gradients, all of which are absent in conventional in vitro models. This evidence concerns the gene NOS2 and neoplasm.